| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $17.8M | +15.8% |
| Cost of Revenue | $13.5M | +57.3% |
| Gross Profit | $4.3M | -36.4% |
| R&D Expense | $1.7M | +11.2% |
| SG&A Expense | $27.8M | -27.6% |
| Operating Income | -$75.1M | -31.3% |
| Pre-tax Income | -$72.5M | -62.2% |
| Income Tax | -$6.4M | -768.8% |
| Net Income | -$66.2M | -44.7% |
| EPS (Basic) | -$1.72 | +3.4% |
| EPS (Diluted) | -$1.72 | +3.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.4M | -66.6% |
| Accounts Receivable | $2.3M | +1.4% |
| Inventory | $8.4M | -45.5% |
| Current Assets | $26.2M | -56.5% |
| Total Assets | $52.1M | -55.1% |
| Current Liabilities | $9.4M | -65.4% |
| Long-term Debt | $1.5M | -93.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$29.1M | +19.8% |
| Capital Expenditures | $1.3M | -82.1% |
| Investing Cash Flow | $1.2M | +116.4% |
| Financing Cash Flow | $3.3M | +79.3% |
| Free Cash Flow | -$30.4M | +30.2% |
| Total Liabilities |
| $11.7M |
| -73.1% |
| Stockholders' Equity | $40.4M | -44.5% |